
Breaking Boundaries: SciSparc and Clearmind Medicine Join Forces to Publish Innovative Ketamine-Based Combination Application
SciSparc Announces Collaboration with Clearmind Medicine Inc. TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with…